COVAXIN

Bharat Biotech to make 700 million doses in 2021

Read more

Mixed reactions from healthcare experts, activists over REU for Covaxin, Covishield

Read more

Brazilian Clinics plans deal with Bharat Biotech for five million doses of Covaxin

Read more

Drug activist group AIDAN raises concerns over EUA for COVAXIN

Read more

DCGI approves Covishield and Covaxin for restricted emergency use in India

Read more

COVAXIN clinical trials recruit 23,000 subjects

Read more

SEC recommends EUA for Covaxin from Bharat Biotech

Read more

Vice President Venkaiah Naidu meets Bharat Biotech CMD, discusses status of Covaxin

Read more

Phase I clinical trial outcome shows Covaxin generates antibody, T-cell memory response

Read more

Ocugen and Bharat Biotech to Co-develop COVAXIN for US market

Read more